Kathryn E Wengel is Director of LABORATORY CORP OF AMERICA HOLDINGS. Currently has a direct ownership of 2,292 shares of LH, which is worth approximately $546,962. The most recent transaction as insider was on Feb 07, 2024, when has been sold 947 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.29K
0% 3M change
70.41% 12M change
Total Value Held $546,962

Kathryn E Wengel Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 07 2024
BUY
Exercise of conversion of derivative security
-
947 Added 29.24%
2,292 Common Stock
Feb 11 2023
BUY
Exercise of conversion of derivative security
-
742 Added 35.55%
1,345 Common Stock
Mar 25 2022
BUY
Exercise of conversion of derivative security
-
603 Added 50.0%
603 Common Stock

Also insider at

JNJ
JOHNSON & JOHNSON Healthcare
KEW

Kathryn E Wengel

Director
New Brunswick, NJ

Track Institutional and Insider Activities on LH

Follow LABORATORY CORP OF AMERICA HOLDINGS and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LH shares.

Notify only if

Insider Trading

Get notified when an Laboratory Corp Of America Holdings insider buys or sells LH shares.

Notify only if

News

Receive news related to LABORATORY CORP OF AMERICA HOLDINGS

Track Activities on LH